Clinical Features, Treatment, and Survival of Patients With Colorectal Cancer With or Without Inflammatory Bowel Disease  Raja Affendi Raja Ali, Cara Dooley, Harry Comber, John Newell, Laurence John Egan  Clinical Gastroenterology and Hepatology  Volume 9, Issue 7, Pages 584-589.e2 (July 2011) DOI: 10.1016/j.cgh.2011.04.016 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 (A) The Kaplan–Meier estimated survivor function of unmatched IBD CRC and non-IBD CRC patients. (B) The Kaplan–Meier estimated survivor function for the propensity score-matched IBD CRC and non-IBD CRC patients. Clinical Gastroenterology and Hepatology 2011 9, 584-589.e2DOI: (10.1016/j.cgh.2011.04.016) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Pruned survival tree for the matched dataset with estimated Kaplan–Meier survivor functions at each terminal node. Clinical Gastroenterology and Hepatology 2011 9, 584-589.e2DOI: (10.1016/j.cgh.2011.04.016) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 1 Annual cases of IBD and non-IBD CRC from 1994 to 2005. Clinical Gastroenterology and Hepatology 2011 9, 584-589.e2DOI: (10.1016/j.cgh.2011.04.016) Copyright © 2011 AGA Institute Terms and Conditions